[About the estimation of non specific protective effect of vaccination against infections actual for military personnel].

Flue and other respiratory diseases morbidity of servicemen of training students are researched. Epidemiological and economic effectiveness of flue vaccine "Bakcuspun" (Vaksigrip) is estimated. Its non-specific protective effect in case of acute respiratory diseases and pyodermia is shown.

[Examination of the contamination aetiological agent of legionellosis in the water supply systems of medical treatment facilities].

This study considers the features of colonization of water distribution systems by Legionella in large multi-type health-care facilities in Moscow-city, Russia. The investigation of 16 pavilions in 5 multi-type health-care facilities had found the hith level of hot water systems contaminated by Legionella pneumophila (68%), including the risk units. Among the different species of Legionella pneumophila, circulating in hot water systems of health-care facilities, the following strains had prevailed: the serogroup 6 (44%), 5 (26%) and 1 (13%). The findings conclude that certain prevention measures should be taken for microbial control and ensuring water safety in water systems of health-care facilities to prevent the nosocomial cases of legionellosis.

[About non-specific prophylaxis of infections typical for organized groups].

Respiratory tract infections and pyodermia are typical for personnel doing military service under conscription. Risk of progression of these infections is connected with activation of carry-over of causative agents among military personnel during replacement and decrease in immunity of conscripts. Usage of medication "Karmolis Kapli" for the purpose of prophylaxis allows to reduce cases of respiratory tract infections among the military personnel. Among the military servicemen who had take "Karmolis Kapli" was noted reduction of community-acquired pneumonia, tonsillitis and pyodermia morbidity. Non-specific protective effect of medication "Karmolis Kapli" is conditioned by increase of the common resistance of the body. For the purpose of prophylaxis it is necessary to use this medication during the personnel formation before the beginning of seasonal morbidity.

[Effect of imunofan on several indexes of immunity and pyoderma incidence among cadets of educational institutes].

It was discovered that during the first several months military service men have suppression of several indexes of immunity and a high level of morbidity by pyoderma. Was shown a high effectiveness of immunomodulatory agent Imunofan on correction of immunity status of servicemen and decrease of morbidity by pyoderma (more than on threefold): the effectiveness index is 3,25, the defense index is 69,2%. In addition, it was marked hepatitis- and stress-protect effect of the agent. It was made a conclusion about necessity of further examination of questions of correction of immunity status of military servicemen for the purpose of decrease of morbidity by infections, actual for studying units of the Armed Forces of RF.

[Organizational-epidemiological aspects of prophylaxis of community-acquired pneumonias in Moscow military district].

The article presents broad information, which is the result of longstanding observation (2002-2006) There are also presented adequate financial data. The article unfolds peculiarities of multiyear and annual dynamics of morbidity rate by out-hospital pneumonias in Moscow military circuit, educes and proves the basic risk factors of disease, shows its value. The accent is made on military and study units. Recommendations on lowering morbidity rate by out-hospital pneumonias, existing in the article, are based on the own experience of the authors, their effectiveness is proved by real positive results.

[Arbidol used in the prophylaxis of acute respiratory viral infections and their complications in servicemen]. / Profilaktika arbidolom ostrykh respiratornykh virusnykh infektsii i ikh oslozhnenii u voennosluzhashchikh.

The prophylactic action of arbidol to prevent the acute respiratory viral infections and their complications (extra-hospital pneumonia) was studied under conditions of two military collectives during winter and summer time. The data obtained confirm the prophylactic activity of the drug in respect of ARVI. Regardless of the degree of disease epidemic rise among the servicemen who didn't take arbitol the minimal threshold of grippe and other ARVI incidence (10-15%) remained in the experimental group. The incidence of pneumonia decreased. It was connected with decrease in viral-and-bacterial pneumonia. The number of patients with bacterial (generally pneumococcal) pneumonia didn't change.

[Pharmacologic and cold therapy in severe chronic ischemia of the lower extremities]. / Farmakokholodovaia terapiia pri tiazheloi khronicheskoi ishemii nizhnikh konechnostei.

It was demonstrated experimentally and in the clinic that pharmacocoid therapy applied before, during, and after operation produces a protective anti-ischemic and spasmolytic effect, prevents of reduces the intensity of reperfusion disorders, and allows the viability of the limb involved in severe chronic ischemia to be appraised.